Total number of publications: 43
2005
-
Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
Journal of Biological Inorganic Chemistry, year: 2005, volume: 10, edition: 7
2004
-
DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
Biochemical Pharmacology, year: 2004, volume: 67, edition: 6
-
Vliv ultrazvuku na DNA a na tvorbu komplexu DNA s doxorubicinem
Sborník XXVII.Dny lékařské biofyziky 2004, year: 2004
2003
-
Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action
Journal of Biological Chemistry, year: 2003, volume: 278, edition: 48
-
DNA Binding Mode of the Cis and Trans Geometries of New Antitumor Nonclassical Platinum Complexes Containing Piperidine, Piperazine, or 4-Picoline Ligand in Cell-Free Media. Relations to Their Activity in Cancer Cell Lines
Biochemistry, year: 2003, volume: 42, edition: 20
2002
-
A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464
Journal of Biological Inorganic Chemistry, year: 2002, volume: 2002, edition: 7
-
Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium
Journal of Biological Inorganic Chemistry, year: 2002, volume: 7, edition: 7
2001
-
Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464
Journal of Biological Chemistry, year: 2001, volume: 276, edition: 25
-
Different recognition of DNA modified by antitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53
Journal of Biological Chemistry, year: 2001, volume: 276, edition: 19
-
Differential recognition of DNA modified by antitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53
Journal of Biological Chemistry, year: 2001